# Why Not Sirolimus for Active Lupus?

Source: [MedPageToday.com - medical news for physicians](https://www.medpagetoday.com/meetingcoverage/acr/123790) · 2026-11-09 · Medicine
Page: https://themorning.science/story/why-not-sirolimus-for-active-lupus-d56668db9c959125
Kind: research · Impact: low

## In brief

- A trial from China tested a daily oral dose of sirolimus in patients with systemic lupus erythematosus (SLE) whose disease was uncontrolled despite standard therapy.
- Patients did well on the treatment, according to the trial as reported by MedPage Today from the ACR meeting in Orlando.
- Safety concerns were not entirely resolved by the results.

## Why it matters

Sirolimus is an existing immunosuppressant, so a positive signal in refractory lupus could inform future treatment options for patients who are not controlled on standard therapy, though the safety questions need further evaluation.

## Coverage

- [Why Not Sirolimus for Active Lupus?](https://www.medpagetoday.com/meetingcoverage/acr/123790) — MedPageToday.com - medical news for physicians, 2026-11-09

Tags: lupus, sirolimus, clinical trial, autoimmune disease, immunosuppression

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science